By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Castle Biosciences 



Houston  Texas    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Diagnostics






Company News
Castle Biosciences Release: Study Demonstrates Significant And Risk-Appropriate Clinical Impact Of DecisionDx-Melanoma Test Results On Patient Management Decisions 5/15/2017 8:55:39 AM
Oxford Finance And Silicon Valley Bank Close $20 Million Credit Facility With Castle Biosciences 5/11/2017 8:04:42 AM
Castle Biosciences’ Decisiondx-Melanoma Test Accurately Predicts Metastatic Risk In Patients With Head And Neck Melanoma 5/1/2017 8:08:39 AM
Blue Cross Blue Shield Association Evidence Street Issues Positive Assessment Of Castle Biosciences’ Uveal Melanoma Gene Expression Test 3/29/2017 6:30:10 AM
Castle Biosciences Release: Study Demonstrates That Decisiondx-Melanoma Test Improves Identification Of High Risk Skin Melanoma When Used With AJCC Outcome Prediction Tool 1/23/2017 7:52:01 AM
Castle Biosciences Release: New Laboratory Receives Accreditation From College of American Pathologists 1/17/2017 7:46:20 AM
Castle Biosciences Announces Launch Of New Eye Cancer Test To Measure Expression Of PRAME Gene 10/10/2016 11:19:52 AM
Study Results With Castle Biosciences’ Uveal Melanoma Gene Expression Test Published In Journal Of Oncology 8/10/2016 12:35:43 PM
Castle Biosciences Announces Clinical Results Of Melanoma Gene Expression Test In Stage I And II Cohort Study At 2016 American Academy of Dermatology Summer Meeting 7/28/2016 10:13:50 AM
Results Of New Study With Castle Biosciences’ Skin Melanoma Gene Expression Test Published In Current Medical Research And Opinion 7/11/2016 8:48:22 AM
12345
//-->